Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Genentech
Company Monitoring Page for Genentech
latest headlines for company on cafepharma
Amgen and Genentech are the latest drug makers to lay off workers
Stat
Sat, 11/4/17 - 07:23 pm
Tags:
Amgen
,
Genentech
,
layoffs
,
R&D
,
drug manufacturing
,
Merck
,
drug reps
[forum discussion]Huge Headcount Reductions
Cafepharma Message Boards
Mon, 10/16/17 - 09:46 am
Tags:
layoffs
,
Genentech
[forum discussion]Should rank reports be eliminated?
Cafepharma Message Boards
Thu, 10/12/17 - 09:26 am
Tags:
drug reps
,
MS
,
multiple sclerosis
,
Genentech
New target could yield treatment for Alzheimer's, ALS and more
Fierce Biotech
Thu, 08/17/17 - 09:57 am
Tags:
Genentech
,
Roche
,
drug development
,
R&D
,
Alzheimer's disease
,
ALS
Exelixis and Genentech hammer out new deal terms
BioPharma Dive
Fri, 07/21/17 - 10:10 am
Tags:
Exelixis
,
Genentech
,
Cotellic
,
melanoma
Roche looks into PML report for Ocrevus patient
BioPharma Dive
Thu, 05/25/17 - 11:25 am
Tags:
Roche
,
PML
,
Ocrevus
,
Genentech
,
MS
,
multiple sclerosis
Roche unit Genentech takes on Pfizer with new lung cancer data
BioPharma Dive
Mon, 04/10/17 - 11:09 am
Tags:
Roche
,
Genentech
,
Pfizer
,
Xalkori
,
Alecensa
,
non-small cell lung cancer
Study evaluates drug-device combo therapy for deep vein thrombosis
Drug Delivery Business News
Mon, 03/6/17 - 07:39 pm
Tags:
drug-device combos
,
devices
,
DVT
,
deep vein thrombosis
,
PCDT
,
Medtronic
,
Boston Scientific
,
BSN Medical
,
Genentech
The Demise of the BPCIA Patent Dance?
FDA Law Blog
Fri, 03/3/17 - 09:40 am
Tags:
BPCIA
,
patents
,
Genentech
,
Amgen
,
Sandoz
,
Avastin
Amgen and the BPCIA Patent Dance – Redux
FDA Law Blog
Mon, 02/20/17 - 10:07 am
Tags:
Amgen
,
patents
,
BPCIA
,
FDA
,
Sandoz
,
Neupogen
,
generics
,
Genentech
,
Avastin
Can the new CEO at Genentech maintain a tradition of groundbreaking R&D?
Endpoints
Thu, 12/15/16 - 12:05 pm
Tags:
Genentech
,
Pharma CEOs
,
R&D
,
Bill Anderson
,
Ian Clark
FDA Accepts Genentech's Biologics License Application For Subcutaneous Formulation Of Rituximab
Yahoo
Fri, 11/4/16 - 09:18 am
Tags:
FDA
,
Genentech
,
Halozyme
,
rituximab
,
blood cancer
Drug and device makers paid $6.5 billion to docs and teaching hospitals last year
Stat
Fri, 07/1/16 - 10:29 am
Tags:
physician payments
,
physicians
,
devices
,
pharma industry
,
Novartis
,
Genentech
,
Pfizer
Drug makers pay $67m for misleading docs about cancer drug survival data
Stat
Mon, 06/6/16 - 11:21 pm
Tags:
Roche
,
Genentech
,
OSI Pharmaceuticals
,
False Claims Act
,
whistleblower lawsuits
,
Tarceva
,
non-small cell lung cancer
Five Storylines To Watch At ASCO
Forbes
Tue, 05/31/16 - 11:14 am
Tags:
ASCO 2016
,
drug pricing
,
Pfizer
,
Ibrance
,
breast cancer
,
Tecentriq
,
Genentech
,
Roche
,
PDL-1 inhibitors
Genentech accused again of cheating health care providers
Stat
Sat, 05/21/16 - 12:38 pm
Tags:
Genentech
,
Roche
,
Herceptin
AbbVie wins FDA approval for leukemia drug
BioPharma Dive
Mon, 04/11/16 - 05:22 pm
Tags:
AbbVie
,
FDA
,
Venclexta
,
CLL
,
Genentech
J&J joins up with Genentech for a pair of atezo/Darzalex combo cancer studies
Fierce Biotech
Tue, 03/22/16 - 04:06 pm
Tags:
JNJ
,
Genentech
,
Darzalex
,
atezolizumab
You'll Never Guess Which Pharma Likely Owns 40% of 2016's New Blockbusters
Motley Fool
Sat, 03/19/16 - 02:41 pm
Tags:
Roche
,
Genentech
,
ocrelizumab
,
atezolizumab
,
venetoclax
Top asthma drug at Roche posts 1 win, 1 flop in identical PhIIIs
Fierce Biotech
Mon, 02/29/16 - 10:30 am
Tags:
Roche
,
Genentech
,
asthma
,
clinical trials
,
lebrikizumab
Pages
« first
‹ previous
…
8
9
10
11
12
13
14
15
16
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.